Mezzion Pharma Co.Ltd (140410) — Net Asset Quality Index
Mezzion Pharma Co.Ltd (140410) has a Net Asset Quality Index of 15.7% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩98.92 Billion minus total liabilities of ₩83.41 Billion yields net assets of ₩15.51 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Mezzion Pharma Co.Ltd (140410) total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Mezzion Pharma Co.Ltd Net Asset Quality Index Over Time (2012–2025)
This chart shows how Mezzion Pharma Co.Ltd's Net Asset Quality Index has evolved across 12 annual periods from 2012 to 2025. As of March 2026, the index stands at 15.7%, representing net assets of ₩15.51 Billion against total assets of ₩98.92 Billion KRW. For live market cap and overall valuation, see market value of Mezzion Pharma Co.Ltd.
Annual Net Asset Quality Index for Mezzion Pharma Co.Ltd (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Mezzion Pharma Co.Ltd from 2012 to 2025, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Mezzion Pharma Co.Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 17.5% | ₩17.19 Billion | ₩98.02 Billion | ₩80.83 Billion | ▼ -44.7 pp |
| 2024 | 62.2% | ₩46.06 Billion | ₩74.00 Billion | ₩27.94 Billion | ▼ -4.4 pp |
| 2023 | 66.7% | ₩61.44 Billion | ₩92.15 Billion | ₩30.70 Billion | ▲ +18.1 pp |
| 2022 | 48.6% | ₩26.24 Billion | ₩54.02 Billion | ₩27.78 Billion | ▼ -26.2 pp |
| 2021 | 74.8% | ₩62.79 Billion | ₩83.93 Billion | ₩21.14 Billion | ▼ -0.3 pp |
| 2020 | 75.1% | ₩56.81 Billion | ₩75.63 Billion | ₩18.82 Billion | ▲ +2.4 pp |
| 2019 | 72.7% | ₩42.83 Billion | ₩58.87 Billion | ₩16.04 Billion | ▼ -3.6 pp |
| 2018 | 76.4% | ₩57.32 Billion | ₩75.06 Billion | ₩17.74 Billion | ▲ +4.6 pp |
| 2017 | 71.8% | ₩53.17 Billion | ₩74.04 Billion | ₩20.87 Billion | ▲ +16.7 pp |
| 2016 | 55.1% | ₩52.81 Billion | ₩95.90 Billion | ₩43.09 Billion | ▼ -5.6 pp |
| 2015 | 60.7% | ₩62.54 Billion | ₩103.05 Billion | ₩40.52 Billion | ▼ -33.4 pp |
| 2012 | 94.1% | ₩63.34 Billion | ₩67.30 Billion | ₩3.97 Billion | — |